Showing results (361-370 of 377) with videos related to

Sort By:
Pageof 38
Journal of Pharmacological and Toxicological Methods|June 21, 2025
Current practices on the measurement of electrocardiogram and hemodynamic parameters in non-rodent species in regulatory safety assessment studiesJean-Pierre Valentin, Todd Bourcier, Xuan Chi, et al.
Interventional Cardiology (London, England)|July 23, 2026
Intravascular Ultrasound in Percutaneous Coronary Intervention: A Consensus Document from the UKJohn Hung, Brian Cox, Michael Foley, et al.
Journal of Medicinal Chemistry|July 9, 2025
Discovery of Orally Efficacious Bridged Piperazines as smTNF ModulatorsZhiguo Bian, Robert G Schmidt, Noel S Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2021
Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasomeStanley C Xie, Riley D Metcalfe, Hirotake Mizutani, et al.
The Journal of Biological Chemistry|April 3, 2016
i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4Katherine Griffiths, Olan Dolezal, Benjamin Cao, et al.
Journal of Medicinal Chemistry|January 11, 2023
Structure-Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors─Part IIHao Zhang, John Ginn, Wenhu Zhan, et al.
ACS Omega|August 8, 2026
Structure-Activity Relationship Study of Antimalarial Asparagine-Derived Proteasome InhibitorsHao Zhang, Daqiang Li, Hao-Chi Hsu, et al.
Journal of Medicinal Chemistry|May 5, 2021
Macrocyclic Peptides that Selectively Inhibit the Mycobacterium tuberculosis ProteasomeHao Zhang, Hao-Chi Hsu, Shoshanna C Kahne, et al.
Research Square|August 7, 2023
Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetaseStanley C Xie, Yinuo Wang, Craig J Morton, et al.
Pageof 38